(Q37718744)

22 August 2017

title

Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis (English)

1 reference

pancreatic adenocarcinoma

22 August 2017

1 reference

1 reference

Skye C Mayo

1

1 reference

22 August 2017

Donald F Austin

2

1 reference

22 August 2017

Brett C Sheppard

3

1 reference

22 August 2017

Motomi Mori

4

1 reference

22 August 2017

Donald K Shipley

5

1 reference

22 August 2017

Kevin G Billingsley

6

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

116

1 reference

22 August 2017

issue

12

1 reference

22 August 2017

page(s)

2932-2940

1 reference

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

The pathologist and the residual tumor (R) classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Outcome after pancreaticoduodenectomy for periampullary cancer: an analysis from the Veterans Affairs National Surgical Quality Improvement Program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma--part 3: update on 5-year survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Periampullary adenocarcinoma: analysis of 5-year survivors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Variations in Surgical Treatment and Outcomes of Patients With Pancreatic Cancer: A Population-Based Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Adjuvant therapy for pancreatic cancer--the debate continues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Surgeon volume and operative mortality in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Do cancer centers designated by the National Cancer Institute have better surgical outcomes?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Assessment of pancreatic cancer care in the United States based on formally developed quality indicators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25082

7 January 2021

Identifiers

DOI

10.1002/CNCR.25082

1 reference

22 August 2017

1 reference